Brief: Sedana Medical: Positive Top Line Result In Pivotal IsoConDa Study

Sedana Medical AB (publ)

10/07/2020 06:03

July 10 (Reuters) - Sedana Medical AB (publ)  SEDANA.ST :
    * SEDANA MEDICAL ANNOUNCES POSITIVE TOP LINE RESULT IN
PIVOTAL
ISOCONDA STUDY
    * STUDY REACHED ITS PRIMARY ENDPOINT; TO SHOW THAT ISOCONDA
(ISOFLURANE), ADMINISTERED WITH ANACONDA, IS AN EFFECTIVE
SEDATION METHOD, FOR VENTILATOR-INTENSIVE CARE PATIENTS, WHICH
IS NON-INFERIOR TO PROPOFOL
    * SECONDARY ENDPOINTS ARE UNDER ANALYSIS AND WILL BE
PUBLISHED
TOGETHER WITH PRIMARY ENDPOINT IN A SCIENTIFIC JOURNAL AFTER
PEER-REVIEW.
    * RESULTS INDICATE THAT ISOCONDA IS AN EFFECTIVE AND SAFE
SEDATION
METHOD AND WILL FORM BASIS FOR COMPANY'S APPLICATION FOR
EUROPEAN MARKET APPROVAL LATER THIS AUTUMN.

Source text for Eikon:  ID:nWkr1F38fd 
Further company coverage:  SEDANA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))